Ribbon Acquisition Business Summary

Ribbon Acquisition Corp. (RIBB) operates as a special purpose acquisition company (SPAC), or "blank check" entity, structured to facilitate a business combination through a merger, capital stock exchange, or asset acquisition. The company currently generates no operational revenue, with its financial profile defined by interest income from its trust account and a focus on the "Shell Companies" sector within the financial services industry. In July 2025, Ribbon entered into a definitive business combination agreement with DR.C Medical Medicine Co., Ltd. (DRC Medicine), a biotechnology firm, in a reverse merger transaction valued at approximately $350 million. As of February 2026, the company has extended its consummation deadline to January 16, 2027, to finalize this transition into the healthcare and life sciences market. Within the competitive landscape of micro-cap SPACs, Ribbon competes directly with entities such as American Exceptionalism Acquisition Corp. (AEXA), Soren Acquisition Corp. (SORNU), and Bleichroeder Acquisition Corp. II (BBCQ), distinguishing itself through a strategic mandate that specifically excludes targets with primary operations in Greater China. The leadership team is anchored by Chairman and CEO Angshuman "Bubai" Ghosh, who brings over 27 years of experience in international finance, including high-level roles at Goldman Sachs (Japan) and Lehman Brothers Japan, and is the founder of KG Partners Ltd. Supporting him is CFO Zhiyang "Anna" Zhou, a veteran of the SPAC space who previously served as CFO for Chenghe Group and held executive positions at China Orient Asset Management and Anbang Asset Management. The board of directors features significant technical and venture pedigree, including James Zhao-Hui Zhang, a co-founder of Mendel Biotechnology and former venture partner at Softbank China Venture Capital, and Dr. Kani Chen, a fintech expert and director at the Hong Kong University of Science and Technology. Institutional backing for the vehicle includes notable positions from HGC Investment Management Inc. and Clear Street LLC, reflecting a sophisticated investor base focused on the company's ability to execute complex cross-border transactions.